Neurotoxicity in murine striatal dopaminergic pathways following long-term application of low doses of permethrin and MPTP

Toxicology Letters

Volumn 171, Issue 3, 2007, Pages 154-161

  Kou, Jinghong ^a   Bloomquist, Jeffrey R ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Synuclein; Dopamine transporter; Parkinson's disease; Striatum; Tyrosine hydroxylase; Vesicular monoamine transporter

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALPHA SYNUCLEIN; DOPAMINE TRANSPORTER; PERMETHRIN; TETRABENAZINE; TYROSINE 3 MONOOXYGENASE; VESICULAR MONOAMINE TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

AFFINITY LABELS; ALPHA-SYNUCLEIN; ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; INSECTICIDES; MICE; MICE, INBRED C57BL; MPTP POISONING; NEOSTRIATUM; NEURAL PATHWAYS; PERMETHRIN; TETRABENAZINE; TYROSINE 3-MONOOXYGENASE; UP-REGULATION;

MURINAE; MUS; PARKINSONIA;

EID: 34447343340     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2007.05.005     Document Type: Article

References (37)

1. Abdel-Rahman A., Shetty A.K., and Abou-Donia M.B. Subchronic dermal application of N,N-diethyl m-toluamide (DEET) and permethrin to adult rats, alone or in combination, causes diffuse neuronal cell death and cytoskeletal abnormalities in the cerebral cortex and the hippocampus, and Purkinje neuron loss in the cerebellum. Exp. Neurol. 172 (2001) 153-171
2. Abou-Donia M.B., Wilmarth K.R., Jensen K.F., Oeheme F.W., and Kurt T.L. Neurotoxicity resulting from coexposure to pyridostigmine bromide, DEET, and permethrin: implications of gulf war chemical exposures. J. Toxicol. Environ. Health 48 (1996) 35-56
3. Abou-Donia M.B., Wilmarth K.R., Abdel-Rahman A., Jensen K.F., Oeheme F.W., and Kurt T.L. Increased neurotoxicity following concurrent exposure to pyridostigmine bromide, DEET, and chlorpyrifos. Fund. Appl. Toxicol. 34 (1996) 201-222
4. Alam M., and Schmidt W.J. Rotenone destroys dopaminergic neurons and induces Parkinsonian symptoms in rats. Behav. Brain Res. 136 (2002) 317-324
5. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., and Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3 (2000) 1301-1306
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
7. 3H]1-methyl-4-phenyl-2,3-dihydropyridinium ion to mouse striatal membranes: putative vesicular location. Eur. J. Pharmacol. 202 (1991) 293-294
8. Doherty J.D., Morii N., Hiromori T., and Ohnishi J. Pyrethroids and the striatal dopaminergic system in vivo. Comp. Biochem. Physiol. C 91 (1988) 371-375
9. Elwan M.A., Richardson J.R., Guillot T.S., Caudle W.M., and Miller G.W. Pyrethroid pesticide-induced alterations in dopamine transporter function. Toxicol. Appl. Pharmacol. 211 (2006) 188-197
10. Fleming L., Mann J.B., Bean J., Briggle T., and Sanchez-Ramos J.R. Parkinson's disease and brain levels of organochlorine pesticides. Ann. Neurol. 36 (1994) 100-103
11. Fleming S.M., Zhu C., Fernagut P.O., Mehta A., DiCarlo C.D., Seaman R.L., and Chesselet M.F. Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone. Exp. Neurol. 187 (2004) 418-429
12. Gillette J.S., and Bloomquist J.R. Differential up-regulation of striatal dopamine transporter and alpha-synuclein by the pyrethroid insecticide permethrin. Toxicol. Appl. Pharmacol. 192 (2003) 287-293
13. Heikkila R.E., and Sonsalla P.K. The MPTP-treated mouse as a model of Parkinsonism: how good is it?. Neurochem. Int. 20 (1992) 299S-303S
14. Hertzman C., Wiens M., Bowering D., Snow B., and Calne D. Parkinson's disease: a case-control study of occupational and environmental risk factors. Am. J. Ind. Med. 17 (1990) 349-355
15. Jimenez-Jimenez F.J., Mateo D., and Gimenez-Roldan S. Exposure to well water and pesticides in Parkinson's disease: a case-control study in the Madrid area. Mov. Disord. 7 (1992) 149-152
16. Karen D.J., Li W., Harp P.R., Gillette J.S., and Bloomquist J.R. Striatal dopaminergic pathways as a target for the insecticides permethrin and chlorpyrifos. Neurotoxicology 22 (2001) 811-817
17. Kirby M.L., Castagnoli K., and Bloomquist J.R. In vivo effects of deltamethrin on dopamine neurochemistry and the role of augmented neurotransmitter release. Pestic. Biochem. Physiol. 65 (1999) 160-168
18. Kou J., Gillette J.S., and Bloomquist J.R. Neurotoxicity in murine striatal dopaminergic pathways following co-application of permethrin, chlorpyrifos and MPTP. Pestic. Biochem. Physiol. 85 (2006) 68-75
19. Krechniak J., and Wrzesniowska K. Effects of pyrethroid insecticides on hepatic microsomal enzymes in rats. Environ. Res. 55 (1991) 129-134
20. Miller G.W., Erickson J.D., Perez J.T., Penland S.N., Mash D.C., Rye D.B., and Levey A.I. Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease. Exp. Neurol. 156 (1999) 138-148
21. Peter D., Jimenez J., Liu Y., Kim J., and Edwards R.H. The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors. J. Biol. Chem. 269 (1994) 7231-7237
22. Rajput A.H., Uitti R.J., Stern W., and Laverty W. Early onset Parkinson's disease in Saskatchewan-environmental considerations for etiology. Can. J. Neurol. Sci. 13 (1986) 312-316
23. Rao G.V., and Rao K.S. Inhibition of monoamine oxidase-A of rat brain by pyrethroids-an in vitro kinetic study. Mol. Cell. Biochem. 124 (1993) 107-114
24. Salach J.I., Singer T.P., Castagnoli Jr. N., and Trevor A. Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP. Biochem. Biophys. Res. Commun. 125 (1984) 831-835
25. Seidler A., Hellenbrand W., Robra B.P., Vieregge P., Nischan P., Joerg J., Oertel W.H., Ulm G., and Schneider E. Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology 46 (1996) 1275-1284
26. Sherer T.B., Kim J.H., Betarbet R., and Greenamyre J.T. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp. Neurol. 179 (2003) 9-16
27. Snodgrass H.l. Permethrin transfer from treated cloth to the skin surface: potential for exposure in humans. J. Toxicol. Environ. Health 35 2 (1992) 91-105
28. Soderlund D.M., Clark J.M., Sheets L.P., Mullin L.S., Piccirillo V.J., Sargent D., Stevens J.T., and Weiner M.L. Mechanisms of pyrethroid neurotoxicity: implications for cumulative risk assessment. Toxicology 171 (2002) 3-59
29. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., and Goedert M. Alpha-synuclein in Lewy bodies. Nature 388 (1997) 839-840
30. Sundstrom E., Fredriksson A., and Archer T. Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease. Brain Res. 528 (1990) 181-188
31. Tillerson J.L., Caudle W.M., Reveron M.E., and Miller G.W. Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Exp. Neurol. 178 (2002) 80-90
32. Tomalik-Scharte D., Lazar A., Meins J., Bastian B., Ihrig M., Wachall B., Jetter A., Tantcheva-Poor I., Mahrle G., and Fuhr U. Dermal absorption of permethrin following topical administration. Eur. J. Clin. Pharmacol. 61 (2005) 399-404
33. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 76 (1979) 4350-4354
34. Upadhya S.C., Boyd M.R., and Ravindranath V. Characterization and localization of cytochrome P450 mediated metabolism of MPTP to nor-MPTP in mouse brain: relevance to Parkinosn's disease. Neurotox. Res. 3 (2001) 369-380
35. Vila M., Vukosavic S., Jackson-Lewis V., Neystat M., Jakowec M., and Przedborski S. Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP. J. Neurochem. 74 (2000) 721-729
36. Wright A.M., Bempong J., Kirby M.L., Barlow R.L., and Bloomquist J.R. Effects of haloperidol metabolites on neurotransmitter uptake and release: possible role in neurotoxicity and tardive dyskinesia. Brain Res. 788 (1998) 215-222
37. Xu Z., Cawthon D., McCastlain K.A., Slikker Jr. W., and Ali S.F. Selective alterations of gene expression in mice induced by MPTP. Synapse 55 (2005) 45-51